Showing results (11-20 of 3,769) with videos related to
Sort By:
Pageof 377
Current Topics in Medicinal Chemistry|May 30, 2025
Design, Synthesis, Molecular Docking, and Biological Evaluation of 7-Phenyl-5-(thiophen-2-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones as Antibacterial AgentsMallika Agrawal, Adarsh Kumar, Ankit Kumar Singh, et al.Drug Discovery Today|December 9, 2023
Medicinal chemistry aspects of uracil containing dUTPase inhibitors targeting colorectal cancerNabeel Backer, Adarsh Kumar, Ankit Kumar Singh, et al.Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|May 20, 2024
A comprehensive review on pharmacognosy, phytochemistry and pharmacological activities of 8 potent species of southeast AsiaShikha Agrawal, Adarsh Kumar, Ankit Kumar Singh, et al.RSC Medicinal Chemistry|March 7, 2025
Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspectiveVineet Prajapati, Ankit Kumar Singh, Adarsh Kumar, et al.Chemistry & Biodiversity|August 4, 2023
Phytochemical Profiling and Pharmacological Evaluation of Leaf Extracts of Ruellia tuberosa L.: An In Vitro and In Silico ApproachAkanksha Sharma, Adarsh Kumar, Ankit Kumar Singh, et al.Chemistry & Biodiversity|March 6, 2026
Unrevealing the Multifaceted Role of Resveratrol as Potential Antioxidant and Anticancer Agent: Molecular Mechanism and Future PerspectivesArvind Sharma, Adarsh Kumar, Ravi P Chaudhary, et al.Journal of Computer-Aided Molecular Design|October 25, 2025
Pyrimidin-4-bromobenzenesulfonamide/-4-nitrobenzenesulfonamide hybrids as potential BRAFV600E inhibitors: experimental, computational and biological evaluationsAnkit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.Scientific Reports|October 8, 2025
Targeted design, synthesis, molecular dynamics, ADME and in -vitro anticancer assessment of oxo-tetrahydro-pyrimidin-benzenesulfonamide hybrids as potential BRAFV600E inhibitorsAnkit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.RSC Advances|March 3, 2023
Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agentsAdarsh Kumar, Kuber Kumar Bhagat, Ankit Kumar Singh, et al.RSC Medicinal Chemistry|October 20, 2023
MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectivesTeja Ram, Ankit Kumar Singh, Adarsh Kumar, et al.Pageof 377